BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

65.23

+0.56 (0.87%)

At close: Aug 31, 2026, 4:00 PM EDT

65.23

0.00 (0.00%)

Pre-market: Sep 1, 2026, 8:16 AM EDT

BioMarin Pharmaceutical Revenue by Segment

Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Voxzogo	963.41M	932.27M	926.39M	861.39M	833.19M	795.70M	734.60M	672.30M
Voxzogo Growth	15.63%	17.16%	26.11%	28.13%	37.60%	48.76%	56.36%	71.99%
Naglazyme	507.33M	500.94M	484.87M	474.87M	484.77M	487.90M	479.50M	467.80M
Naglazyme Growth	4.65%	2.67%	1.12%	1.51%	8.99%	21.10%	14.09%	10.72%
Palynziq	458.73M	429.50M	432.94M	407.94M	389.54M	371.90M	354.60M	342.40M
Palynziq Growth	17.76%	15.49%	22.09%	19.14%	17.79%	17.21%	16.64%	18.68%
Brineura	195.47M	192.80M	185.69M	184.69M	173.69M	170.30M	169.30M	164.90M
Brineura Growth	12.54%	13.21%	9.68%	12.00%	2.84%	5.32%	4.64%	2.55%
Aldurazyme	183.28M	196.18M	208.44M	198.44M	215.44M	197.60M	183.90M	187.60M
Aldurazyme Growth	-14.93%	-0.72%	13.34%	5.78%	65.21%	49.58%	40.17%	48.65%
Kuvan	95.32M	97.91M	99.03M	104.03M	108.13M	109.70M	120.60M	129.30M
Kuvan Growth	-11.85%	-10.74%	-17.88%	-19.54%	-24.96%	-33.96%	-33.26%	-34.56%
Royalty and Other	42.01M	49.12M	53.49M	49.93M	46.51M	43.98M	44.48M	45.90M
Royalty and Other Growth	-9.67%	11.69%	20.27%	8.78%	-1.26%	-7.99%	-4.96%	0.44%
Roctavian	30.35M	27.84M	36.20M	34.20M	38.40M	36.60M	26.40M	18.10M
Roctavian Growth	-20.96%	-23.95%	37.12%	88.94%	228.20%	751.16%	654.29%	2,162.50%